Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

304 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The Untapped Potential of Pharmacy Leaflets for Informing Patients About Drug Benefits and Risks.
Hung A, Sieluk J, Doshi P. Hung A, et al. Among authors: doshi p. JAMA Intern Med. 2016 Jan;176(1):11-2. doi: 10.1001/jamainternmed.2015.6656. JAMA Intern Med. 2016. PMID: 26618769 No abstract available.
For-profit Uses of Real-World Data: What Would Frances Kelsey Do?
Zito JM, Doshi P. Zito JM, et al. Among authors: doshi p. Med Care. 2016 Dec;54(12):1045-1047. doi: 10.1097/MLR.0000000000000647. Med Care. 2016. PMID: 27846130 No abstract available.
Informed Consent to Study Purpose in Randomized Clinical Trials of Antibiotics, 1991 Through 2011.
Doshi P, Hur P, Jones M, Albarmawi H, Jefferson T, Morgan DJ, Spears PA, Powers JH 3rd. Doshi P, et al. JAMA Intern Med. 2017 Oct 1;177(10):1452-1459. doi: 10.1001/jamainternmed.2017.3820. JAMA Intern Med. 2017. PMID: 28828473 Free PMC article.
Neuraminidase Inhibitors and Influenza Infection.
Doshi P, Jefferson T. Doshi P, et al. JAMA Intern Med. 2016 Mar;176(3):415-6. doi: 10.1001/jamainternmed.2016.0016. JAMA Intern Med. 2016. PMID: 26954053 No abstract available.
Transparency interrupted: the curtailment of the European Medicines Agency's Policy on access to documents.
Doshi P. Doshi P. JAMA Intern Med. 2013 Nov 25;173(21):2009-11. doi: 10.1001/jamainternmed.2013.9989. JAMA Intern Med. 2013. PMID: 23959623 No abstract available.
Pharmacists can help to end direct-to-consumer advertising.
Kuzucan A, Doshi P, Zito JM. Kuzucan A, et al. Among authors: doshi p. Am J Health Syst Pharm. 2017 May 15;74(10):640-642. doi: 10.2146/ajhp160927. Am J Health Syst Pharm. 2017. PMID: 28483941 No abstract available.
ADHD medications and cardiovascular adverse events in children and adolescents: cross-national comparison of risk communication in drug labeling.
Sieluk J, Palasik B, dosReis S, Doshi P. Sieluk J, et al. Among authors: doshi p. Pharmacoepidemiol Drug Saf. 2017 Mar;26(3):274-284. doi: 10.1002/pds.4164. Epub 2017 Jan 13. Pharmacoepidemiol Drug Saf. 2017. PMID: 28083936
Contribution of industry funded post-marketing studies to drug safety: survey of notifications submitted to regulatory agencies.
Spelsberg A, Prugger C, Doshi P, Ostrowski K, Witte T, Hüsgen D, Keil U; Working Group on Health and Working Group on Freedom of Information, Transparency International Deutschland eV. Spelsberg A, et al. Among authors: doshi p. BMJ. 2017 Feb 7;356:j337. doi: 10.1136/bmj.j337. BMJ. 2017. PMID: 28174182 Free PMC article.
Challenges of independent assessment of potential harms of HPV vaccines.
Jørgensen L, Doshi P, Gøtzsche P, Jefferson T. Jørgensen L, et al. Among authors: doshi p. BMJ. 2018 Sep 24;362:k3694. doi: 10.1136/bmj.k3694. BMJ. 2018. PMID: 30249615 No abstract available.
Communication of Nonefficacy Benefits of New Drugs Approved on the Basis of Noninferiority Trials Alone: Cohort Study of FDA and Sponsor Communication, 2011-2017.
Doshi P, Spence O, Kuzucan A, Powers JH 3rd. Doshi P, et al. JAMA Intern Med. 2019 May 1;179(5):719-721. doi: 10.1001/jamainternmed.2018.7040. JAMA Intern Med. 2019. PMID: 30830158 Free PMC article.
304 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback